Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains ...

Illumina said adding SomaLogic would support the company’s multiomics strategy and strengthen the value of its NovaSeq X ...

Illumina is diving deeper into proteomics research with a $425 million plan to acquire SomaLogic, including its protein ...

Cash & Cash Equivalents of At Least $550 Million Expected at Close to Fuel Inorganic Growth Strategy and Drive Long-Term Value Creation. SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- ...

Recent collaborations highlight a growing interest in building a multiomics-based understanding of health and disease.

Cash & Cash Equivalents of At Least $550 Million Expected at Close to Fuel Inorganic Growth Strategy and Drive Long-Term Value Creation SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE ...

The amplicon nanoballs are extracted and sequenced on a conventional Illumina platform. In Phase 3, multimodal data were integrated through a computational pipeline to capture what DNA was found ...

June 26, 2025, is the 25th anniversary of the White House announcement of the first sequencing of the human genome, and July 28, 2025, marks the 30th anniversary of the publication of the first ...